Class / Patent application number | Description | Number of patent applications / Date published |
514190100 | Cellular adhesion affecting or cell adhesion molecule (CAM) affecting or utilizing | 8 |
20100323969 | Compounds Binding to P-Selectin - The present invention relates to derivatives of compounds which bind selectively to the adhesion molecule human P-selectin, and particularly to such derivatives which comprise a peptide moiety or a functional equivalent of said peptide moiety and are represented by X(A | 12-23-2010 |
20110034396 | Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions - The present disclosure provides methods of use of saratin, including the prevention or mitigation of the development of adhesions, keloids and scars. The adhesions, keloids and scars can be due to surgery, such as plastic surgery or orthopedic surgery, or can be pre-existing scars. Adhesion, keloid and/or scar formation may also be prevented in surgical procedures utilizing shunts, implants or drainage devices, including surgical procedures to treat glaucoma. | 02-10-2011 |
20110245184 | TREATMENT OF SURGICAL ADHESIONS - Compositions, articles, devices and methods for the treatment and/or prevention of adhesions in humans and non-human animals. | 10-06-2011 |
20110257102 | COMPOSITIONS AND METHODS OF TREATING CANCER - A method of inhibiting neoplastic, cancer, and/or tumorgenic cell proliferation, cell growth and motility in a subject includes administering to a cancer cell expressing Pro-PrP and FLNa a therapeutically effective amount of a Pro-PrP regulating agent. | 10-20-2011 |
20120202748 | RECOMBINANT MUSSEL ADHESIVE PROTEIN FP-131 - The present invention relates to a bio-adhesive derived from mussel. In particular, it relates to a recombinant protein fp(foot protein)-131 that is a hybrid of fp-3 variant A and fp-1. According to the present invention, the recombinant protein with adhesive activity can be economically produced in large scale to be used in place of chemical adhesives. | 08-09-2012 |
20130045924 | METHODS OF REDUCING HYPOXIC STRESS IN A MAMMAL BY ADMINISTERING SOLUBLE P-SELECTIN - The present invention provides a use of soluble P-selectin in treating systemic hemorrhagic conditions, stabilizing blood pressure, and protecting hypoxic/ischemic tissues. Also provided is a use of anthrax lethal toxin in treating thrombotic conditions. | 02-21-2013 |
20140080762 | HYD1 PEPTIDES FOR RELAPSED CANCER - The subject invention pertains to compositions and methods for treatment of malignancies and inhibiting the growth of cancer cells, such as multiple myeloma and other hematologic malignancies, using HYD1 peptides. Other aspects of the invention are directed to methods for selection of agents useful in the treatment of malignancies and inhibiting the growth of cancer cells. Further aspects of the invention include methods for determining whether a cancer is sensitive or resistant to treatment with HYD1 peptides based on the presence of certain biomarkers, such as α4 integrin and CD44 expression. | 03-20-2014 |
20150051152 | PEPTIDE INCREASING FUSIOGENIC CAPACITY OF A GAMETE - The invention relates to a cyclic peptide increasing the fusiogenic capacity of the oocyte arising from the disintegrin loop of fertilin beta, to a pharmaceutical composition comprising said cyclic peptide and to the use thereof, particularly in order to supplement culture media used to carry out in vitro fertilization. | 02-19-2015 |